Drugs Used in Obesity Flashcards

1
Q

What are the problems associated with obesity?

A

increased risk of T2D, CVD, cancer, hypertension, osteoarthritis, asthma, sleep apnoea; increased burden on health care system

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Leptin is released from

A

white adipose tissue

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Where does leptin act in the brain to regulate body weight and energy expenditure?

A

hypothalamus - regulates neuropeptides

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are the current drugs approved for treatment of obesity?

A

Orlistat and Phentermine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What percent of the population is predicted to be obese by 2025?

A

1/3rd

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What population is rapidly gaining weight?

A

ages 25-34; younger people

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What are satiety signals?

A

afferent sympathetic (liver and stomach) or vagal signals (stomach) to the medulla - short-term

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Satiety signals function by

A

afferent sympathetic or vagal signals to the medulla, medulla to hypothalamus; hypothalamus alters neuropeptides that signal to stop eating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

CCK is produced

A

in the GIT in response to digested fats and carbs

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

CCK signals via the ______ nerve to the ______ to ________ eating

A

vagus; medulla & hypothalamus; stop eating

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What are adiposity signals?

A

long-term; provide the brain with information on fat stores (leptin, insulin)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Leptin levels are proportional to

A

fat mass/BMI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

How is leptin transported across the BBB?

A

It is large tf it needs to be actively transported

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How does leptin function once inside the brain?

A

activates receptors on the hypothalamus to inhibit feeding by inhibiting neuropeptides that promote food intake, or promote neuropeptides that inhibit food intake

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Examples of central peptides that increase feeding (orexigenic) are

A

NPY, melanin-concentrating hormone, agouti-related peptide, Orexin A and B, endocannabinoids

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Examples of peripheral peptides that increase feeding (orexigenic) are

A

ghrelin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Examples of central peptides that decrease feeding (anorexigenic) are

A

alpha-MSH, urocortin, corticotrophin releasing hormone, serotonin, NA

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Examples of peripheral peptides that decrease feeding (anorexigenic) are

A

leptin, insulin, CCK

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Why is it hard to alter eating behaviours via single neuropeptides?

A

Altering one leads to compensation by others

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Leptin inhibits food intake via ______ mechanism

A

CNS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Plasma leptin has a ________ rhythm

A

circadian

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

Why does the elevated leptin in obesity not affect the brain?

A

saturation of transport - leptin must be actively transported through the BBB

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

High leptin ______ food intake; low leptin ______ food intake

A

decreases; increases

24
Q

T/F leptin deficiency and receptor defects are the primary cause of obesity in humans

A

False; few patients are leptin-deficient or have receptor defects

25
Q

How does leptin regulate body weight and energy expenditure?

A

High circulating leptin from white adipose tissue signals to the hypothalamus, binding to receptors to alter neuropeptides such that food intake is decreased and energy usage is increased to restore fat stores to normal; the opposite occurs when circulating leptin is low

26
Q

What are the effects of elevated leptin levels in obesity?

A

leptin resistance due to: decrease in sensitivity of hypothalamic leptin receptors; failure/insensitivity of second messenger systems; decrease in sensitivity of BBB transport systems because they are saturated (tf less leptin gets into the brain)

27
Q

What are the current central drug targets of food intake?

A

inhibitors: NA, serotonin; stimulators: CB1 antagonists, NPY & AgRP antagonists, aMSH antagonists

28
Q

What are the current peripheral drug targets of food intake?

A

Leptin

29
Q

What are the current drug targets of fat absorption?

A

lipase inhibitors (orlistat)

30
Q

What are the current drug targets to increase thermogenesis?

A

B3-aR agonists - B3s on skeletal muscle and fat

31
Q

Phentermine is a ___________

A

sympathomimetic amine

32
Q

What is the action of phentermine?

A

acts within the CNS to increase NA (also DA and 5HT) known to inhibit food intake

33
Q

What is the limitation of phentermine use?

A

can only be used for 3 weeks and tolerance develops; bc sympathomimetic, higher doses can be dangerous

34
Q

Orlistat is a ____________

A

lipase inhibitor: pancreatic and gastric

35
Q

What is the benefit of orlistat over phentermine?

A

It can be used in the long-term

36
Q

What is the action of orlistat?

A

Inhibits dietary fat absorption by inhibiting pancreatic and gastric lipases

37
Q

For obesity drugs to be effective they must be combined with ________ and ________

A

low calorie diet; increased exercise

38
Q

What is the mechanism of phentermine?

A

selective for increasing NA availability at post-synaptic receptors (also DA and 5HT) by blocking neuronal re-uptake by the presynaptic neuron; this suppresses appetite [may increase energy expenditure]

39
Q

Phentermine use is indicated for patients

A

BMI > 30 or >/ 27 with one co-moribidity (diabetes, cardiac HT)

40
Q

What are the adverse effects of phentermine?

A

sympathomimetic effects: increased BP, HR, insomnia, nervousness; headache, dry mouth; may have addictive euphoric properties

41
Q

What are the contraindications for phentermine?

A

cannot be combined with other drugs that increase catecholamines in the brain eg MAO inhibitor antidepressants; cannot be used in pregnancy

42
Q

What is the primary use of Topiramate?

A

epilepsy and migraine, it blocks VG Na+ and Ca2+ channels, reducing firing; weight loss is a side effect

43
Q

What is the use of Topiramate in obesity?

A

in combination with phentermine it creates a slow-release hormone with a longer half life and a longer time to steady-state (increased tolerability)

44
Q

What is the mechanism of Topiramate?

A

unknown; but it increases energy expenditure and suppresses appetite, and also insulin sensitivity

45
Q

Use of Topiramate is indicated in patients with

A

BMI > 30 or >/27 with one co-morbidity

46
Q

What are the adverse effects of Topiramate?

A

dizziness, taste alteration, teratogenic effects (cleft palate), parasthesia

47
Q

Use of Orlistat is indicated in patients with

A

BMI > 30

48
Q

What are the unique aspects of Orlistat?

A

only drug available for long-term use, and only drug that targets dietary fat intake rather than food intake

49
Q

What is the mechanism of Orlistat?

A

inhibits gastric and pancreatic lipases via covalent binding, preventing hydrolysis of TAGs to FFAs - this decreases dietary fat absorption by ~30%

50
Q

What is the dosing of Orlistat?

A

3x daily with meals, 120mg

51
Q

Orlistat has been shown to improve

A

body weight (60% 5% decrease, 40% 10% decrease) and WHR - 5% reductions in body weight improve BP, blood lipids, glucose and insulin tolerance

52
Q

What are the adverse effects of Orlistat?

A

limited to the GI bc not systemically absorbed; minimal if low-fat diet is adhered to, but after high fat meals they get explosive diarrhoea and faecal fat leakage - this conditions them to eat a lower fat diet

53
Q

Orlistat must be combined with

A

a low fat diet (prevents GI side effects) and fat-soluble vitamin supplements (D & E)

54
Q

The basis for amylin + leptin analogue drugs is

A

amylin works synergistically with insulin to increase the brain’s sensitivity to insulin, creating feelings of satiety and fullness

55
Q

Mechanisms of potential new drugs in obesity include

A

DA & NA reuptake inhibitors; analogues of amylin and leptin; pancreatic lipase inhibitors; long-acting glucagon like peptide analogs; 5HT, DA, and NA reuptake inhibitors; Agouti-related protein inhibitors; Diglyceride acyltransferase inhibitors; NPY receptor antagonist

56
Q

To be effective, drugs used in obesity

A

should have a known mechanism of action of reducing appetite and increasing energy expenditure to limit side effects; reduce body weight and associated medical complications; benefits should outweigh side effects; no addictive properties; should be able to be used long-term